Revilliza, Kevin Patrick F.

HRN: 22-17-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2022
CEFUROXIME 1.5GM (VIAL)
11/07/2022
11/14/2022
IV
1.5
Q8h
For Inguinal Repair
Waiting Final Action 
11/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/07/2022
11/14/2022
IV
500
Q8h
For Inguinal Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: